Literature DB >> 21225948

Engaging hospitalists in antimicrobial stewardship: the CDC perspective.

Arjun Srinivasan1.   

Abstract

There has never been a more important time to promote efforts to improve the use of antibiotics in hospitals. The growing challenges of C. difficile infections and antimicrobial resistance can both be addressed, at least in part, through so called "antimicrobial stewardship" efforts. Data suggest that when the right antibiotics are prescribed at the right dose for the right durations patient outcomes are improved and healthcare dollars are saved. That improving antibiotic use is a win-win-win is not in question; what remains to be determined is how best to ensure that these efforts are implemented in all hospitals. I believe that hospitalists must play an important role in advancing antimicrobial stewardship. This is a US government work.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225948     DOI: 10.1002/jhm.863

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  4 in total

1.  Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention.

Authors:  Loria A Pollack; Arjun Srinivasan
Journal:  Clin Infect Dis       Date:  2014-10-15       Impact factor: 9.079

2.  Can a collaborative subspecialty antimicrobial stewardship intervention have lasting effects?

Authors:  Kaushal B Shah; Ramzy H Rimawi; Mark A Mazer; Paul P Cook
Journal:  Infection       Date:  2017-07-19       Impact factor: 3.553

Review 3.  Investigating the ways in which health information technology can promote antimicrobial stewardship: a conceptual overview.

Authors:  Abby King; Kathrin M Cresswell; Jamie J Coleman; Sarah K Pontefract; Ann Slee; Robin Williams; Aziz Sheikh
Journal:  J R Soc Med       Date:  2017-07-21       Impact factor: 5.344

4.  Towards a global definition of responsible antibiotic use: results of an international multidisciplinary consensus procedure.

Authors:  Annelie A Monnier; Barry I Eisenstein; Marlies E Hulscher; Inge C Gyssens
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.